Updated:
Alwin Capital
Alwin Capital is a Beijing-based private equity asset manager focused on early-stage and growth investments.
Alwin Capital
Alwin Capital is a venture capital firm in China focused on early-stage life science investments. It has made 30 investments, including a Series C investment in Pulimeng on July 31, 2025. The firm has one portfolio exit, Edge Medical, which exited on January 08, 2026.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What stages does Alwin Capital target?
Available strategy tags list early stage seed, start-up, growth, and expansion investments.
Where is Alwin Capital headquartered?
The firm is based in Beijing, China.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: